Exhibit 4.3


 


 


Description of Registrant’s Securities.


 


Capital Stock


 


General


 


The following descriptions of common and preferred
stock summarizes the material terms and provisions of the Company’s common stock and preferred stock, but is not intended to be
complete. For the full terms of the Company’s common and preferred stock, please refer to the Company’s articles of incorporation,
as amended from time to time, and our bylaws, as amended from time to time. The Nevada Revised Statutes may also affect the terms of these
securities.


 


As of March 31, 2021, the Company’s authorized
capital stock consists of 42,000,000 shares of common stock, par value $0.001 per share, of which 22,941,157 shares were issued and outstanding
as of March 31, 2021, and 200,000 shares of preferred stock, par value $0.001, of which no shares were issued and outstanding as of March
31, 2021. The authorized and unissued shares of both common and preferred stock are available for issuance without further action by the
Company’s stockholders, unless such action is required by applicable law, the NASDAQ Capital Market, or the rules of any other stock
exchange on which our securities may be listed. Unless approval of the Company’s stockholders is so required, the Company’s
board of directors will not seek stockholder approval for the issuance and sale of either our common stock or preferred stock.


 


Common Stock


 


The holders of the Company’s common stock are
entitled to one vote per share. Any action required to be taken by the holders of the Company’s common stock at a meeting may, without
prior notice, by taken by written consent in lieu of a meeting if the consent has been signed by the minimum number of holders of common
stock required to approve such action.


 


In addition, the holders of the Company’s common
stock will be entitled to receive ratably such dividends, if any, as may be declared by the Company’s board of directors out of
legally available funds; however, the current policy of the Company’s board of directors is to retain earnings, if any, for operations
and growth. Upon liquidation, dissolution or winding-up, the holders of the Company’s common stock will be entitled to share ratably
in all assets that are legally available for distribution. The holders of the Company’s common stock will have no pre-emptive, subscription,
redemption or conversion rights. The holders of the Company’s common stock do not have cumulative rights in the election of directors.
The rights, preferences and privileges of holders of the Company’s common stock are subject to, and may be adversely affected by,
the rights of the holders of our preferred stock.


 


The Company’s common stock is listed on the
NASDAQ Capital Market under the symbol “NMRD”. The transfer agent and registrar for the Company’s common stock is Nevada
Agency and Stock Transfer Company. Its address is 50 West Liberty Street. Suite 880, Reno, Nevada 89501, and its telephone number is 775-322-0626.


 


Preferred Stock


 


The Company’s board of directors may determine,
in its sole discretion, the powers, designations, preferences, and relative participation, optional or other rights, if any, and the qualifications,
limitations or restrictions thereof, including dividend rights, conversion rights, voting rights, redemption rights, liquidation preference,
sinking fund terms and the number of shares. The rights, preferences, privileges and restrictions of the preferred stock of each series
will be fixed by the certificate of designation relating to that series.


 


 






    	  





    	 



    

 


In October 2017, the Company filed with the Nevada
Secretary of State a Certificate of Designation for up to 200,000 shares of Series A convertible preferred stock. The holders of the Series
A preferred stock have rights superior to the holders of the Company’s common stock as to the distributions of assets upon our liquidation,
dissolution or winding up, whether voluntary or involuntary. The Series A convertible preferred stock shall automatically convert to shares
of common stock at a ratio of 100-for-1, i.e. each share of Series A preferred stock shall convert into 100 shares of common stock, when
the following conditions are met: (a) the sugarBEAT® device has received CE regulatory approval; (b) retail sales of sugarBEAT®
have commenced and (c) such retail sales have exceeded $5 million. Holders of Series A preferred stock may voluntarily convert their shares
after February 7, 2018 at the conversion ratio then in effect, subject to adjustment for any stock splits, combinations, dividends, distributions,
or mergers and acquisitions.


  


The holders of the Series A convertible preferred
stock are entitled to vote, as a class, on all matters voted on by the holders of the Company’s common stock. Each share of Series
A convertible preferred stock is entitled to that number of votes equal to the number of shares of common stock the Series A preferred
stock is convertible into at the time the vote is taken. The holders of the Series A convertible preferred stock shall also vote, as a
class, on all matters that may adversely impact their rights and preferences. The Series A convertible preferred stock is not eligible
for dividend payments and we have no right to redeem these preferred shares. Holders of the Series A convertible preferred stock may transfer
their shares without the Company’s consent.


 


As of March 31, 2021, there were no shares of Series
A convertible preferred stock issued and outstanding.


 


With respect to any future series of preferred stock
to be authorized, the Company will file a certificate of designation with the Secretary of State of the State of Nevada that will specify
the following: the maximum number of shares; the designation of the shares; the annual dividend rate, if any, and whether the dividend
is fixed or variable; the price and terms and conditions for redemption, if any; the liquidation preference, if any; any sinking fund
or similar provision; the terms and conditions, if any, for conversion and exchange of the preferred stock into any other class or classes
of our capital stock or any other of the Company’s securities or assets; and voting rights.


 


The future issuance of shares of preferred stock will
affect, perhaps adversely, the rights of holders of the Company’s common stock. While the Company cannot state the actual effects
of such issuance until the Company’s board of directors determines the specific rights attached to the preferred stock to be issued,
these effects could include: restricting dividends on the common stock; diluting the voting power of the common stock; impairing the liquidation
rights of our common stock; and delaying or preventing changes in our control or management.


 


As of March 31, 2021, the Company had warrants outstanding
to purchase as follows:


 


		·	1,000,000 shares of the Company’s common stock at an exercise price
of $5.00 per share



		·	147,637 shares of the Company’s common stock at an exercise price
of $10.40 per share



		·	792,353 shares of the Company’s common stock at an exercise price
of $8.00 per share



 





The warrants will terminate on the five-year anniversary
of the date of issuance.